Literature DB >> 18468743

Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation.

Margherita Rosati1, Antonio Valentin, Rashmi Jalah, Vainav Patel, Agneta von Gegerfelt, Cristina Bergamaschi, Candido Alicea, Deborah Weiss, Jim Treece, Ranajit Pal, Phillip D Markham, Ernesto T A Marques, J Thomas August, Amir Khan, Ruxandra Draghia-Akli, Barbara K Felber, George N Pavlakis.   

Abstract

We used optimized DNA expression vectors to compare two gene delivery methodologies in rhesus macaques, namely direct DNA injection and in vivo adaptive constant-current electroporation via the intramuscular route. The use of in vivo electroporation increased levels of gene expression and immune responses. We used an optimized HIV gag expression plasmid to show the development of new cellular immune responses in SIV-infected animals controlling viremia. Furthermore, after vaccination with SIV expression plasmids the recall responses to the SIV antigens were very high, indicating that DNA is a strong boost in the presence of antiretroviral treatment in SIV-infected animals. There was substantial animal-to-animal variability in DNA expression, revealed by plasma measurements of IL-15 produced by co-injected IL-15 DNA. IL-15 expression levels correlated with peak immune responses. Electroporation led to an expansion of antigen-specific CD4+ and CD8+ T cells of both central and effector memory phenotype. These results indicate that improved gene delivery and expression by electroporation dramatically increases immunogenicity of DNA vaccines. Electroporation is thus an important method to improve the effectiveness of DNA vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468743      PMCID: PMC7263013          DOI: 10.1016/j.vaccine.2008.03.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

Review 1.  Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases.

Authors:  Gérald J Prud'homme; Yelena Glinka; Amir S Khan; Ruxandra Draghia-Akli
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

Review 2.  Vaccine delivery methods using viral vectors.

Authors:  Andreas Bråve; Karl Ljungberg; Britta Wahren; Margaret A Liu
Journal:  Mol Pharm       Date:  2007 Jan-Feb       Impact factor: 4.939

Review 3.  Prime-boost strategies in DNA vaccines.

Authors:  C Jane Dale; Scott Thomson; Robert De Rose; Charani Ranasinghe; C Jill Medveczky; Joko Pamungkas; David B Boyle; Ian A Ramshaw; Stephen J Kent
Journal:  Methods Mol Med       Date:  2006

Review 4.  DNA vaccines: recent developments and future possibilities.

Authors:  Margaret A Liu; Britta Wahren; Gunilla B Karlsson Hedestam
Journal:  Hum Gene Ther       Date:  2006-11       Impact factor: 5.695

5.  Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.

Authors:  Sampa Santra; Yue Sun; Jenny G Parvani; Valerie Philippon; Michael S Wyand; Kelledy Manson; Alicia Gomez-Yafal; Gail Mazzara; Dennis Panicali; Phillip D Markham; David C Montefiori; Norman L Letvin
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 6.  HIV vaccines: new frontiers in vaccine development.

Authors:  Ann Duerr; Judith N Wasserheit; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2006-07-06       Impact factor: 9.079

7.  Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.

Authors:  G Nasioulas; A S Zolotukhin; C Tabernero; L Solomin; C P Cunningham; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 8.  A review of vaccine research and development: the human immunodeficiency virus (HIV).

Authors:  Marc P Girard; Saladin K Osmanov; Marie Paule Kieny
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

9.  Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

Authors:  L Jean Patterson; Nina Malkevitch; David Venzon; Joel Pinczewski; Victor Raúl Gómez-Román; Liqun Wang; V S Kalyanaraman; Phillip D Markham; Frank A Robey; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.

Authors:  Cristina Bergamaschi; Margherita Rosati; Rashmi Jalah; Antonio Valentin; Viraj Kulkarni; Candido Alicea; Gen-Mu Zhang; Vainav Patel; Barbara K Felber; George N Pavlakis
Journal:  J Biol Chem       Date:  2007-11-30       Impact factor: 5.157

View more
  50 in total

1.  Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.

Authors:  Vainav Patel; Antonio Valentin; Viraj Kulkarni; Margherita Rosati; Cristina Bergamaschi; Rashmi Jalah; Candido Alicea; Jacob T Minang; Matthew T Trivett; Claes Ohlen; Jun Zhao; Marjorie Robert-Guroff; Amir S Khan; Ruxandra Draghia-Akli; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

Review 2.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 3.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

4.  Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Authors:  Viraj Kulkarni; Margherita Rosati; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Cristina Bergamaschi; Ashish K Singh; Candido Alicea; Bhabadeb Chowdhury; Gen-Mu Zhang; Eun-Young Kim; Steven M Wolinsky; Wensheng Huang; Yongjun Guan; Celia LaBranche; David C Montefiori; Kate E Broderick; Niranjan Y Sardesai; Antonio Valentin; Barbara K Felber; George N Pavlakis
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

5.  Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.

Authors:  Malissa C Diehl; Jessica C Lee; Stephen E Daniels; Pablo Tebas; Amir S Khan; Mary Giffear; Niranjan Y Sardesai; Mark L Bagarazzi
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

6.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

7.  DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge.

Authors:  Margherita Rosati; Cristina Bergamaschi; Antonio Valentin; Viraj Kulkarni; Rashmi Jalah; Candido Alicea; Vainav Patel; Agneta S von Gegerfelt; David C Montefiori; David J Venzon; Amir S Khan; Ruxandra Draghia-Akli; Koen K A Van Rompay; Barbara K Felber; George N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

8.  Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.

Authors:  Monica Vaccari; Brandon F Keele; Steven E Bosinger; Melvin N Doster; Zhong-Min Ma; Justin Pollara; Anna Hryniewicz; Guido Ferrari; Yongjun Guan; Donald N Forthal; David Venzon; Claudio Fenizia; Tia Morgan; David Montefiori; Jeffrey D Lifson; Chris J Miller; Guido Silvestri; Margherita Rosati; Barbara K Felber; George N Pavlakis; James Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.

Authors:  Yimin Shi; Lillia Dincheva-Vogel; Charles E Ayemoba; Jeffrey P Fung; Cristina Bergamaschi; George N Pavlakis; Farzin Farzaneh; Karin M L Gaensler
Journal:  Blood Adv       Date:  2018-11-27

10.  Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency.

Authors:  Chih-Ping Mao; Chien-Fu Hung; Tae Heung Kang; Liangmei He; Ya-Chea Tsai; Chao-Yi Wu; T-C Wu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.